Urogen Pharma Ltd. · NASDAQ:URGN
Degnan Chris sold 2,202 Urogen Pharma Ltd. shares (Form 4)
Traded Oct 8, 2026 · Filed Oct 9, 2026
On Oct 8, 2026, Degnan Chris (Chief Financial Officer) sold 2,202 Urogen Pharma Ltd. shares at US$36.69 for US$80,791, leaving 4,561 shares. Filed Oct 9, 2026 (Form 4).
- Sold
- 2,202 shares
- Price
- US$36.69
- Value
- US$80,791
- Holding after
- 4,561 shares
- Trading plan
- No
- Role
- Chief Financial Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Oct 8, 2026 | Ordinary Shares | Option exercise | 4,483 | 6,763 | Direct | |
| Oct 8, 2026 | Ordinary Shares | Sale | 2,202 | US$36.69 | 4,561 | Direct |